Source: FinanzNachrichten

Glycotope: Glycotope, Evotec Agree To Merge Glycotope Antibodies And Evotec's Immune Cell Engager Platform

HAMBURG (dpa-AFX) - Glycotope and Evotec (EVO) said that they reached an agreement to merge Glycotope's antibodies with Evotec's immune cell engager platform for the development of next generation...

Read full article »
Glycotope's Competitors | Glycotope's News | Glycotope's Financials
Stay up-to-date with the latest news on Glycotope
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Henner Kollenberg's photo - Managing Director of Glycotope

Managing Director

Henner Kollenberg

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Glycotope